| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3315 | |||||||||||||||||||||||
| Submitter : | Mrs. Donna Monarch | Date & Time: | 12/15/2006 08:12:23 | |||||||||||||||||||||
| Organization : | Mrs. Donna Monarch | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
|
I am writing to voice my concerns about the use of vaccines that are derived from aborted fetuses. I personally find this practice morally offensive and repugnant. Since, there is proven success at using other methods and cell lines, such as immunizations used in China, I am strongly requesting that American agencies and businesses discontinue using cell lines derived from aborted fetus to create immunizations. | ||||||||||||||||||||||||